Contains:- Active Ingredient：Ondansetron
– Content Specification：4mg per 2mL single dose
– Pharmaceutical Form：Sterile clear injection solution
– Applicable Standard：International pharmacopoeia specification, hospital clinical grade
– Storage Condition：Sealed storage, protected from light and high temperature
– Product Features：Precise fixed-dose packaging, convenient clinical administration, stable efficacy, suitable for large-scale hospital reserve and clinical batch use Each ampoule contain Ondansetron 4mg
– Package: 2ml ampoule *10/ box
Package:
Product Description
- Product Name：Ondansetron Injection
- Specification：4mg/2mL
- Therapeutic Category：Antiemetic Drugs / 5-HT3 Receptor Antagonists
- Core Product Positioning：High-selective antiemetic for clinical routine and emergency use
- Indicated For：Prevention and treatment of nausea and vomiting induced by chemotherapy, radiotherapy and surgery
- Usage Scenario：Oncology department, operating room, radiotherapy department, general ward and emergency department of hospitals
- Applicable Clients：Global medical institutions, hospital procurement centers, pharmaceutical wholesalers and medical supply agencies
Product Overview
Ondansetron Injection 4mg/2mL is a highly selective 5-HT3 receptor antagonist widely used in modern clinical medicine. It effectively blocks serotonin-induced vomiting reflex, providing stable and reliable antiemetic effects with high safety and low side effect incidence.
